METHODS OF DETECTING T CELL RECEPTOR CROSS-REACTIVITY
US Application 63/481,757
Filed on 2023-01-26
Filed on 2023-01-26
Directed acetylation of mRNA through engineered snoRNA adapters
US Application 63/423,714
Filed on 2022-11-08
Filed on 2022-11-08
Implications of CXCR3 Expression on Myeloid Cells for Immunotherapy of Cancer and Myeloid-mediated Disease
US Application 63/423,029
Filed on 2022-11-06
Filed on 2022-11-06
Deep Characterization of Cancer Drug Mechanism of Action by Integrating Large-Scale Genetic and Drug Screens
US Application 63/415,560
Filed on 2022-10-12
Filed on 2022-10-12
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION
US Application 63/381,587
Filed on 2022-10-31
Filed on 2022-10-31
T CELL RECEPTORS TARGETING MUTATED CDKN2A
US Application 63/381,591
Filed on 2022-10-31
Filed on 2022-10-31
HUMAN PAPILLOMAVIRUS AND VARICELLA-ZOSTER VACCINE ANTIGENS AND USES
THEREOF IN CANCER IMMUNOTHERAPY
US Application 63/481,544
Filed on 2023-01-25
Filed on 2023-01-25
PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES
US Application 63/349,829
Filed on 2022-06-07
Filed on 2022-06-07
Topoisomerase Ill (TOP3) inhibitors as antiviral and anticancer compounds based on bisacridines
US Application 63/429,923
Filed on 2022-12-02
Filed on 2022-12-02
Synergistic Interactions For Improved Cancer Treatment
US Application 63/398,450
Filed on 2022-08-16
Filed on 2022-08-16